CareDX: Stock Rally After Medicare Clarity! CareDX Revolutionizes Organ Monitoring with AI Diagnostics!
Reading Time: 3 minutes
Investors in the "Healthcare" sector can breathe a sigh of relief. The sector is currently performing the best with a growth of 8.5%. The "Diagnostics & Research" industry is experiencing a significant momentum with profits of 15.7%. CareDX is showing as a strong beneficiary with an almost 70% price increase over the month. What news has caused this price jump? CareDX provides diagnostic solutions for transplantation medicine Medicare secures coverage for core products AlloSure & AlloMap Revenue rises 39% to 118 million USD thanks...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
